Renaissance Technologies LLC Buys 133,190 Shares of Inotiv, Inc. (NASDAQ:NOTV)

Renaissance Technologies LLC boosted its stake in shares of Inotiv, Inc. (NASDAQ:NOTV - Free Report) by 77.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 304,254 shares of the company's stock after purchasing an additional 133,190 shares during the quarter. Renaissance Technologies LLC owned about 1.17% of Inotiv worth $1,260,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Russell Investments Group Ltd. acquired a new stake in shares of Inotiv in the fourth quarter valued at about $284,000. Tradewinds LLC. bought a new position in Inotiv in the 4th quarter worth approximately $374,000. Perkins Capital Management Inc. acquired a new position in shares of Inotiv during the fourth quarter worth approximately $497,000. LPL Financial LLC bought a new stake in shares of Inotiv in the fourth quarter valued at approximately $136,000. Finally, American Century Companies Inc. acquired a new stake in shares of Inotiv in the fourth quarter worth $163,000. 18.17% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, CEO Robert Jr. Leasure sold 73,617 shares of the stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $3.82, for a total value of $281,216.94. Following the completion of the transaction, the chief executive officer now owns 956,592 shares in the company, valued at approximately $3,654,181.44. This represents a 7.15 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders sold a total of 81,439 shares of company stock valued at $312,475 over the last ninety days. 7.80% of the stock is owned by company insiders.

Inotiv Stock Performance

Inotiv stock traded down $0.04 during mid-day trading on Monday, reaching $2.00. The company had a trading volume of 53,003 shares, compared to its average volume of 744,642. The company has a quick ratio of 1.28, a current ratio of 1.57 and a debt-to-equity ratio of 2.31. The firm has a market cap of $67.27 million, a price-to-earnings ratio of -0.43 and a beta of 4.03. The company has a 50 day moving average of $2.40 and a 200-day moving average of $3.27. Inotiv, Inc. has a 52 week low of $1.15 and a 52 week high of $6.48.

Inotiv (NASDAQ:NOTV - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported ($0.42) earnings per share for the quarter, missing the consensus estimate of ($0.32) by ($0.10). Inotiv had a negative net margin of 25.40% and a negative return on equity of 15.41%. On average, sell-side analysts expect that Inotiv, Inc. will post -0.79 EPS for the current fiscal year.

About Inotiv

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.